ZEPBOUND
NDC 0002-2457, tirzepatide, injection, solution, from Eli Lilly and Company.
- Product NDC
- 0002-2457
- Status
- Listed
- Labeler
- Eli Lilly and Company
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA217806
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0002-2457 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TIRZEPATIDE15 mg/.5mL
Pharmacologic classes
G-Protein-linked Receptor Interactions [MoA]; GLP-1 Receptor Agonist [EPC]; Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]; Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0002-2457-80 | 00002245780 | 4 SYRINGE in 1 CARTON (0002-2457-80) / .5 mL in 1 SYRINGE (0002-2457-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/487cd7e7-434c-4925-99fa-aa80b1cc776bNADAC price for package 00002245780
GET /v1/drugs/nadac/00002245780
Use it
Look up 0002-2457 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0002-2457 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0002-2457. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.